Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 52INDUSTRY 24NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 41Head and Neck Neoplasms 41Uterine Cervical Neoplasms 31Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 23Ovarian Neoplasms 16Urinary Bladder Neoplasms 14Stomach Neoplasms 12Carcinoma, Ovarian Epithelial 12Sarcoma 9Neuroblastoma 9Esophageal Neoplasms 9Fallopian Tube Neoplasms 8Medulloblastoma 7Endometrial Neoplasms 7Biliary Tract Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma Of Esophagus 7Teratoma 6Central Nervous System Neoplasms 6Brain Neoplasms 6Radiation Injuries 5Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Esophageal Squamous Cell Carcinoma 5Brenner Tumor 5Anus Neoplasms 5Urethral Neoplasms 4Testicular Neoplasms 4

Interventions

olaparib 1durvalumab 1Taxes 1Platinum 1Gemcitabine 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cholangiocarcinoma × Cisplatin × Clear all
NCT03768414 2026-01-12

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

SWOG Cancer Research Network

Phase 3 Completed
452 enrolled 17 charts
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡